In this issue:
- Extensive coverage of CX 2023, including a full report of the BASIL-2 randomised controlled trial results
- New guidelines: Chris Twine (Bristol, UK) and Stavros Kakkos (Patras, Greece) highlight key takeaways from soon-to-be-published recommendations on antithrombotic therapy for vascular diseases
- In profile: Rachel Bell (Newcastle upon Tyne, UK)
- Journal highlight: “Biopsychosocial” roadmap set out to address peripheral arterial disease treatment and mental health impacts
- Advertorial: A multidisciplinary group of physicians highlight the benefits of mechanical thrombectomy for improved deep vein thrombosis outcomes
